Principal Financial Group
KITE

Principal Financial Group’s Kite Pharma, Inc. KITE Stock Holding History

Principal Financial Group’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-52,183
Closed -$9.38M – 2323
2017
Q3 		$9.38M Sell
52,183
-1,547
-3% -$216K 0.01% 1281
2017
Q2 		$5.57M Buy
53,730
+46,447
+638% +$3.79M 0.01% 1507
2017
Q1 		$572K Buy
7,283
+12
+0.2% +$742 ﹤0.01% 1901
2016
Q4 		$326K Buy
7,271
+298
+4% +$14.6K ﹤0.01% 1993
2016
Q3 		$390K Buy
6,973
+78
+1% +$4.35K ﹤0.01% 1902
2016
Q2 		$345K Buy
6,895
+1,196
+21% +$58.8K ﹤0.01% 1909
2016
Q1 		$262K Buy
5,699
+720
+14% +$34.9K ﹤0.01% 1957
2015
Q4 		$307K Buy
4,979
+100
+2% +$7.04K ﹤0.01% 1945
2015
Q3 		$272K Buy
4,879
+532
+12% +$33.5K ﹤0.01% 1962
2015
Q2 		$265K Buy
+4,347
New +$248K ﹤0.01% 1983

Principal Financial Group's KITE Position: Q4 2017 in Review

Principal Financial Group sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 52,183 shares — an estimated $9.38M sold.

Principal Financial Group first reported a position in KITE in Q2 2015 and held it in 10 quarters. The position peaked at $9.38M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Principal Financial Group reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Principal Financial Group sold 52,183 Kite Pharma, Inc. shares in Q4 2017, an estimated $9.38M.
  • Principal Financial Group first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 10 quarters.
  • Principal Financial Group's Kite Pharma, Inc. position peaked at $9.38M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Principal Financial Group's 13F filing for Q4 2017, filed 13 Feb 2018.